Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for moderately active ulcerative colitis in adult participants.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
Collaborators
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT06810518 · Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Inflammatory Bowel Syndrome
NCT06372613 · Ulcerative Colitis in Histologic Remission
NCT07550673 · Acute Severe Ulcerative Colitis
NCT07374471 · Ulcerative Colitis (UC)
Center for Digestive Health (Colonoscopy Location)
Dothan, Alabama
Digestive Health Specialists
Dothan, Alabama
Dothan Eyecare-Dr. Brent McKinley (OCT Location)
Dothan, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions